Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Epidemiology and cost of herpes zoster and postherpetic neuralgia among patients treated in primary care centres in the Valencian community of Spain.

Cebrián-Cuenca AM, Díez-Domingo J, San-Martín-Rodríguez M, Puig-Barberá J, Navarro-Pérez J; Herpes Zoster Research Group of the Valencian Community.

BMC Infect Dis. 2011 Nov 1;11:302. doi: 10.1186/1471-2334-11-302.

2.

Herpes zoster and postherpetic neuralgia in Catalonia (Spain).

Salleras L, Salleras M, Salvador P, Soldevila N, Prat A, Garrido P, Domínguez A.

Hum Vaccin Immunother. 2015;11(1):178-84. doi: 10.4161/hv.34421. Epub 2014 Nov 1. Erratum in: Hum Vaccin Immunother. 2016 Dec;12 (12 ):3213.

3.

Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study.

Gialloreti LE, Merito M, Pezzotti P, Naldi L, Gatti A, Beillat M, Serradell L, di Marzo R, Volpi A.

BMC Infect Dis. 2010 Aug 3;10:230. doi: 10.1186/1471-2334-10-230.

4.

Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom.

Gauthier A, Breuer J, Carrington D, Martin M, Rémy V.

Epidemiol Infect. 2009 Jan;137(1):38-47. doi: 10.1017/S0950268808000678. Epub 2008 May 9.

PMID:
18466661
5.

Health economic evaluation of vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia in Germany.

Ultsch B, Weidemann F, Reinhold T, Siedler A, Krause G, Wichmann O.

BMC Health Serv Res. 2013 Sep 26;13:359. doi: 10.1186/1472-6963-13-359.

6.

Cost of shingles: population based burden of disease analysis of herpes zoster and postherpetic neuralgia.

Friesen KJ, Chateau D, Falk J, Alessi-Severini S, Bugden S.

BMC Infect Dis. 2017 Jan 13;17(1):69. doi: 10.1186/s12879-017-2185-3.

7.

Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.

Pellissier JM, Brisson M, Levin MJ.

Vaccine. 2007 Nov 28;25(49):8326-37. Epub 2007 Oct 17.

PMID:
17980938
8.

Economic Burden of Herpes Zoster ("culebrilla") in Latin America.

Rampakakis E, Pollock C, Vujacich C, Toniolo Neto J, Ortiz Covarrubias A, Monsanto H, Johnson KD.

Int J Infect Dis. 2017 May;58:22-26. doi: 10.1016/j.ijid.2017.02.021. Epub 2017 Mar 4.

9.

Epidemiology and cost of herpes zoster and postherpetic neuralgia in Germany.

Ultsch B, Köster I, Reinhold T, Siedler A, Krause G, Icks A, Schubert I, Wichmann O.

Eur J Health Econ. 2013 Dec;14(6):1015-26. doi: 10.1007/s10198-012-0452-1. Epub 2012 Dec 28.

PMID:
23271349
10.

The potential cost-effectiveness of vaccination against herpes zoster and post-herpetic neuralgia.

Brisson M, Pellissier JM, Camden S, Quach C, De Wals P.

Hum Vaccin. 2008 May-Jun;4(3):238-45. Epub 2010 May 25.

PMID:
18382137
11.

Measuring the burden of herpes zoster and post herpetic neuralgia within primary care in rural Crete, Greece.

Lionis CD, Vardavas CI, Symvoulakis EK, Papadakaki MG, Anastasiou FS, Antonopoulou MD, Apostolakis CM, Dimitrakopoulos SA, Fountakis GI, Grammatikopoulos IA, Komninos JD, Kounalakis DK, Ladoukaki ES, Makri KV, Petraki CS, Ploumis NG, Prokopiadou DP, Stefanaki IN, Tsakountakis NA, Tsiligianni IG, Tzortzis EN, Vasilaki AA, Vasilopoulos TK, Vrentzos GE.

BMC Fam Pract. 2011 Dec 6;12:136. doi: 10.1186/1471-2296-12-136.

12.

Community and patient values for preventing herpes zoster.

Lieu TA, Ortega-Sanchez I, Ray GT, Rusinak D, Yih WK, Choo PW, Shui I, Kleinman K, Harpaz R, Prosser LA.

Pharmacoeconomics. 2008;26(3):235-49.

PMID:
18282017
13.

Burden of herpes zoster and postherpetic neuralgia in Japanese adults 60 years of age or older: Results from an observational, prospective, physician practice-based cohort study.

Sato K, Adachi K, Nakamura H, Asano K, Watanabe A, Adachi R, Kiuchi M, Kobayashi K, Matsuki T, Kaise T, Gopala K, Holl K.

J Dermatol. 2017 Apr;44(4):414-422. doi: 10.1111/1346-8138.13639. Epub 2016 Dec 5.

14.

Predictors of postherpetic neuralgia among patients with herpes zoster: a prospective study.

Drolet M, Brisson M, Schmader K, Levin M, Johnson R, Oxman M, Patrick D, Camden S, Mansi JA.

J Pain. 2010 Nov;11(11):1211-21. doi: 10.1016/j.jpain.2010.02.020.

PMID:
20434957
15.

Predictors of postherpetic neuralgia in patients with herpes zoster: a pooled analysis of prospective cohort studies from North and Latin America and Asia.

Kawai K, Rampakakis E, Tsai TF, Cheong HJ, Dhitavat J, Covarrubias AO, Yang L, Cashat-Cruz M, Monsanto H, Johnson K, Sampalis JS, Acosta CJ.

Int J Infect Dis. 2015 May;34:126-31. doi: 10.1016/j.ijid.2015.03.022. Epub 2015 Apr 2.

16.

Incidences of Herpes Zoster and Postherpetic Neuralgia in Japanese Adults Aged 50 Years and Older From a Community-based Prospective Cohort Study: The SHEZ Study.

Takao Y, Miyazaki Y, Okeda M, Onishi F, Yano S, Gomi Y, Ishikawa T, Okuno Y, Mori Y, Asada H, Yamanishi K, Iso H.

J Epidemiol. 2015;25(10):617-25. doi: 10.2188/jea.JE20140210. Epub 2015 Sep 19.

17.

Epidemiology of herpes zoster infection among patients treated in primary care centres in the Valencian community (Spain).

Cebrián-Cuenca AM, Díez-Domingo J, Rodríguez MS, Puig-Barberá J, Navarro-Pérez J; 'Herpes Zoster Research Group of the Valencian Community'.

BMC Fam Pract. 2010 May 6;11:33. doi: 10.1186/1471-2296-11-33.

18.

[Herpes Zoster and its prevention in Italy. Scientific consensus statement].

Franco E, Gabutti G, Bonanni P, Conversano M, Stefano Valente ME, Ferro A, Icardi G, Antonio Volpi ML, Maggi S, Rossi A, Scotti S, Vitale F, Greco D; Italian Universities and Epidemiology.

Ig Sanita Pubbl. 2014 Jan-Feb;70(1):111-27. Italian.

PMID:
24770367
19.

Herpes zoster and postherpetic neuralgia: optimizing management in the elderly patient.

Johnson RW, Wasner G, Saddier P, Baron R.

Drugs Aging. 2008;25(12):991-1006. doi: 10.2165/0002512-200825120-00002. Review.

PMID:
19021299
20.

Health care utilization and cost burden of herpes zoster in a community population.

Yawn BP, Itzler RF, Wollan PC, Pellissier JM, Sy LS, Saddier P.

Mayo Clin Proc. 2009 Sep;84(9):787-94. doi: 10.1016/S0025-6196(11)60488-6. Erratum in: Mayo Clin Proc. 2010 Jan;85(1):102.

Supplemental Content

Support Center